Recent genomic surveillance indicates that SARS-CoV-2 continues to circulate primarily through Omicron sublineages such as XFG and NB.1.8.1, none of which have met the criteria for variant of concern designation by the WHO or ECDC as of April 2026. Strains like BA.3.2, first noted in late 2024 and detected more widely in wastewater and clinical samples through early 2026, show increased immune escape potential yet no clear rise in severity or transmissibility that would trigger a higher classification. Public health agencies maintain routine monitoring without evidence of a major shift since the last updates to tracking definitions in 2023. This pattern of incremental evolution within existing lineages supports the strong trader consensus favoring no new variant of concern emerging before 2027.